(340-400 nm) 18 by selectively changing the spectrum of solar sunlight received by the skin. 19 Given the need for long-wavelength UVA protection and the absence of meaningful information regarding such protection on currently marketed sunscreen products, 20 there is an urgent demand for a reliable, versatile, and universally applicable method that provides purposeful, SPF-independent information regarding UVA photoprotection. Several in vivo methods using human subjects have been proposed [21] [22] [23] but are not widely accepted. Although there are several reasons for this, the limitation of all proposed human studies of UVA photoprotection is the absence of an end-point measure that is a true surrogate marker for UVA-induced skin damage, especially carcinogenesis and photoaging. From a more practical perspective, the existing human studies utiStrategies aimed at reducing overexposure to sunlight include the use of topical sunscreens. 2, 3 To date, sunscreen product protection has been defined by efficacy in prevention of UV-induced erythema, determined directly by the standard in vivo sun protection factor (SPF) procedure. 4 The action spectrum for UV-induced erythema is well known 5, 6 and largely confined to wavelengths from 290 to 330 nm. In addition, the erythema action spectrum is nearly identical to that proposed for DNA damage 7, 8 and the induction of nonmelanoma skin tumors in mice and, by extension, humans. 9 Thus the SPF test provides a clinically relevant in vivo measure of sunscreen product efficacy, which appears also to be a surrogate for chronic skin damage.
It has become apparent that longer wavelengths of solar UV can contribute to skin damage. This assertion is based on both clinical evidence and theoretical considerations. The studies by Lavker et al, 10, 11 Lavker and Kaidbey, 12 and Lowe et al 13 provide evidence that repeated exposure to an artificial source of long-wavelength UVA produces morphologic changes in human skin indicative of photodamage. These data corroborate studies in animals in which exposure to UVA was reported to accelerate photodamage 14, 15 and the induction of skin tumors. 16, 17 Because the overwhelming majority of sunscreen products available to consumers provide protection primarily limited to UVB and short-wavelength UVA2 (320-340 nm), it has even been hypothesized that the use of such products may paradoxically increase exposure to long-wavelength UVA1 sun protection factor UV: ultraviolet
Fig 1.
Absorption spectrum for hypothetical sunscreen product. UV attenuation is determined at fixed intervals across UV spectrum using substrate spectrophotometry. Wavelength below which 90% of the area under the whole absorption spectrum from 290 to 400 nm falls is the critical wavelength. The shape of the absorption spectrum is independent of application density.
teristic of in vitro calculations of absolute protection factors. As well, the critical wavelength determination does not promote the false notion of UVB and UVA as separate entities, but rather as part of a continuous electromagnetic spectrum. Examples of the critical wavelength determination are illustrated in Fig 2. The shaded areas in Fig 2 represent 90% of the area-underthe-absorption curve from 290 to 400 nm. The critical wavelength for a UVB sunscreen (Fig 2, A) is less than that of a broad-spectrum product (Fig 2, B) . Therefore the objective of the present studies was to evaluate the accuracy, versatility, and in vivo relevance of in vitro UV substrate spectrophotometry and the calculated critical wavelength as a usable measure of UVA photoprotection.
MATERIAL AND METHODS

Substrate preparation
Synthetic collagen substrate with simulated skin topography (Vitro-Skin, Innovative Measurement Solutions Inc, Milford, Conn) was placed in a constant environment chamber (22°C ± 2°C; 80%-90% relative humidity), roughened side up, for at least 24 hours. After this controlled hydration step, the collagen sheet was cut into 9 × 10.2 cm rectangles and returned to the constant environment chamber to maintain homeostasis.
Product samples and application
Commercially available sunscreen products were purchased in June 1997 from retail stores located in Cincinnati, Ohio. Model sunscreen creams were also prepared as oil-in-water emulsions using a similar formula matrix containing varying concentrations of UV filters, solvents, or emollients as needed. Product, 1 mg/cm 2 (absolute quantity, 91.8 mg), was applied uniformly to the roughened side of the hydrated synthetic collagen with a presaturated finger cot. The product film was then allowed to dry under ambient conditions (22°C ± 2°C) for 15 minutes.
UV source
Samples were irradiated with broad-band UV radiation from an Oriel 1000 W Xenon Arc Solar Simulator (Oriel Corp, Stratford, Conn), the output of which was filtered (dichroic mirror, Oriel filters 81017 and 81018) to simulate a solar UV spectrum. The mean UV irradiance (290-400 nm) from the solar simulator was 6.1 mW/cm 2 , as measured at sample height using a calibrated spectroradiometer (model 754, Optronics Co, Orlando, Fla).
Preirradiation of sunscreen products
Except for the photostability study, all sunscreen samples applied to collagen substrate were preirralize end points that (1) are redundant with SPF testing (ie, erythema) 24 ; (2) are oxygen and, by definition, UV dose-rate dependent [25] [26] [27] ; (3) are skin-type dependent; and (4) in some cases require extraordinary exposures to an artificial UVA source, the human health consequences of which are as yet unknown.
Thus several in vitro alternatives to such approaches have been developed.
One such method proposed by Diffey 28 makes no assumptions regarding the action spectra for UVAinduced acute or chronic skin damage and obviates the need for human subjects utilizing clinical end points with indeterminate value in relation to protection from sunlight. This proposed in vitro method is based on the absorption spectrum of a sunscreen product, illustrated in Fig 1, which is obtained by means of UV substrate spectrophotometry. The absorption spectrum is reduced to a single index termed critical wavelength, defined as the wavelength at which the integral of the spectral absorbance curve reached 90% of the integral from 290 to 400 nm. Importantly, the critical wavelength value is based on the inherent shape of the absorbance curve, not its amplitude, and therefore is independent of application thickness and other undesirable variables charac- 
Continued on page 1028
where A is absorption and λ wavelength. For each absorption spectrum, the integrals, which represent the area-under-the-product absorbance curve, were estimated using trapezoidal integration. For each product film, the critical wavelength was the average of 8 determinations. The final critical wavelength value for each product or model sunscreen was the 95% lower confidence limit computed from the 5 individual replicates.
Experimental design Study I. The critical wavelength values of 59 sunscreen products marketed in the United States were measured according to the procedures described above. The products included creams, lotions, and oils intended for daily or recreational use.
Study II. The relationship between the critical wavelength and SPF was studied with two model sunscreens. Oil-in-water emulsions containing 6% octyl methoxycinnamate (OMC) and either 3.5% ZnO or 4% TiO 2 were prepared with an estimated SPF equal to 15. Similar products with an estimated SPF equal to 30 were prepared by the addition of 10% octocrylene (OCTO), a UVB/UVA2 absorber. The estimated SPF was determined by comparing the in vitro absorbance curves for the model sunscreens with those from marketed products in which SPF had been determined in vivo. The absorption spectrum was measured and critical wavelength value determined for all 4 model sunscreen products.
Study III. Model sunscreen creams were prepared with each of the 11 UV filters currently in use. The absorption spectrum of each model cream was then measured and the critical wavelength determined. A model sunscreen product containing the diated with a total UV dose in joules per square centimeter numerically equal to one third the labeled (commercial products) or expected (model sunscreen formulations) product SPF (eg, for an SPF 15 product, preirradiation was 5 J/cm 2 ). Product preirradiation was performed to account for changes that can occur in the absorption spectrum of UV filters. In the photostability study, product samples were preirradiated with solar-simulated UV at total doses ranging from 0 to 30 J/cm. 2 
Absorbance measurements
Immediately after preirradiation, the UV absorbance of the product film was measured using a Labsphere UV-1000S UV transmittance analyzer (Labsphere Inc, North Sutton, NH). Reference absorbance measurements were performed on the 9 × 10.2 cm rectangular piece of untreated, hydrated Vitro-Skin with the Labsphere UV-1000S. After application, the product was allowed to dry. UV absorbance of the product film was measured at 8 different sites on the collagen substrate. For each product sample, 5 independent replicate product films were prepared and evaluated as described above. The measurement performed on the product sample was corrected for the untreated reference and the resulting absorbance curve used to calculate the critical wavelength.
Critical wavelength determination
The critical wavelength was calculated with the following equation: UV filters with the lowest and highest critical wavelength values, 2-phenylbenzimidazole-5-sulfonic acid (PBSA) and AVO, respectively, was also prepared. The absorption spectrum and critical wavelength were then determined. Study IV. The spectral photostability of 4 model sunscreens was determined by means of substrate spectrophotometry. Model SPF 15 sunscreens with different combinations of UV filters were prepared. The absorption spectrum and resulting critical wavelength were determined initially and then after irradiation with 10, 20, and 30 J/cm 2 of solar simulated UV.
Study V. The relationship between in vivo determinations of UVA protection and critical wavelength was investigated. Phototoxic protection factors (PPFs) for several experimental sunscreen products were obtained from Gange et al, 29 Lowe et al, 30 and Lowe. 31 PPF is determined by measuring the minimal phototoxic dose of UVA in protected versus unprotected skin. The phototoxic skin response (ie, erythema) is obtained by topical administration of 8-methoxypsoralen followed by irradiation with an artificial light source filtered to emit a continuous spectrum of UVA (320-400 nm) radiation. Model sunscreen products were prepared with the use of combinations and concentrations of the UV filters reported in these studies. The absorbance spectrum was measured for each product and the critical wavelength determined. Only 10% (6/59) of the commercial products had a critical wavelength of 370 nm or more. The products that achieved a critical wavelength of 370 nm or more contained a recognized UVA1 filter (ie, titanium dioxide [TiO 2 ], zinc oxide [ZnO], or AVO). Not all products with these sunscreens achieved a critical wavelength greater than or equal to 370 nm. This demonstrates that effective concentration and appropriate formulation are essential and that simply including UVA1 filters in a formulation does not ensure a true broad-spectrum product. All of the commercial products having critical wavelengths of 370 nm or greater were SPF 8 or SPF 15.
RESULTS
Study I
Analysis of variance (Kruskal-Wallis test) showed no dependence (P = .98) of critical wavelength on SPF for products of SPF15 and higher (Fig 3) . However, as illustrated in Fig 3, when all SPF groups were included (SPF 4-45), there was a tendency for the critical wavelengths of low SPF products (SPF 4 and 8) to be generally lower than high (SPF ≥ 15) products.
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J AM ACAD DERMATOL VOLUME 43, NUMBER 6 ingredients in model creams. All of the ingredients were evaluated at their current maximum allowable concentration except PBSA, which was incorporated at a concentration of 2%, and the two inorganic active ingredients, TiO 2 and ZnO, which were incorporated at concentrations of 15%, because of limitations with the standard formulation matrix to accommodate greater amounts of these sunscreen active ingredients. Model sunscreen creams containing the UV filters PBSA, OSAL, homosalate (HSAL), octyl dimethyl para-aminobenzoic acid (OPABA), OMC, OCTO, and OXY had critical wavelengths below 370 nm. Model sunscreen creams containing the recognized longwavelength UVA1 filters, AVO, TiO 2 , and ZnO had critical wavelengths of 370 nm or greater.
Study II
The effect of doubling the product SPF on critical wavelength is presented in Table II . In the two examples evaluated, products estimated to provide an SPF of 15 were created by combining OMC with either TiO 2 or ZnO. The critical wavelength for each product was 372 and 376 nm, respectively. When 10% OCTO was added to the formulations to increase the UVB/UVA2 absorbance and provide an estimated SPF of 30, the critical wavelength values were markedly reduced to below 370 nm. Table III presents the critical wavelength, UV attenuation, and peak absorbance for 11 sunscreen active Solid bar represents UV attenuation (expressed in nanometers squared) and is based on substrate spectrophotometry determinations. Filters were prepared in a representative oil-in-water emulsion. Shaded bar represents peak absorbance. *The maximum concentration established in the Sunscreen Drug Products for Over-the-Counter Human Use; final monograph. † Determined at 2% oil-in-water emulsion. ‡ Determined at 15% oil-in-water emulsion. § Shape of the UV attenuation spectra varies with particle size.
Study III
The UV absorption for the combination of 1.5% PBSA and 3% AVO is presented in Fig 4. These UV filters represent the extremes of UV absorption ranges for the 11 UV filters evaluated and, consequently, the largest difference in critical wavelength values. As illustrated in Fig 4, both PBSA and avobenzone have relatively broad-band UV attenuation. When these 2 UV filters are combined, there are no obvious "holes" or "gaps" in the full absorption spectrum.
Study IV
The effect of increasing doses of UV before irradiation (0, 10, 20, 30 J/cm 2 ) on the critical wavelength value of 4 model sunscreens is presented in Fig 5. The model sunscreen products consisting of OMC + TiO 2 , OMC + ZnO, and OCTO + AVO had the same critical wavelength after preirradiation up to 30 J/cm 2 . In contrast, a prototype product with a combination of active ingredients comprising OMC, OSAL, and AVO had significantly lower critical wavelengths concurrent with increasing doses of UV preirradiation. The critical wavelength decreased from 379 nm with no preirradiation to 357 nm after 30 J/cm 2 of UV preirradiation; these spectrally derived data were indicative of photoinstability on a molecular level.
Study V
The relationship between the phototoxic protection factor (PPF) and critical wavelength is presented in Fig 6. Values for PPF were obtained from Gange et al, 29 Lowe et al, 30 and Lowe. 31 There was a linear correlation between the PPF and critical wavelength for products with an SPF of 3 or 4 (r = 0.99) and those with SPFs of 9 to 15 (r = 0.98).
DISCUSSION
From these studies, it appears that most current sunscreen products available to US consumers do not provide significant broad-spectrum UV protection even though the majority of products evaluated (80% of SPF 4-45 and 98% of SPF 15-45) claim some UVA protection. This is primarily due to the lack of a coherent broad-spectrum test and labeling system, a situation that is extant in Europe. As a direct consequence, UVA or broad-spectrum claims may currently be made for sunscreen products simply on the basis of inclusion of a UVA1 or UVA2 filter, regardless of amplitude or breadth of wavelength protection
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Fig 4.
Absorption spectrum and critical wavelength for 1.5% PBSA (critical wavelength = 324 nm), 3% AVO (critical wavelength = 383 nm), and their combination (critical wavelength = 378 nm). PBSA, AVO, and their combination were prepared as oil-in-water emulsions and the absorption spectrum determined by means of substrate spectrophotometry. PBSA has the lowest critical wavelength and AVO the highest. The UV filters alone and in combination have broad absorption spectra. cated to the consumer in an understandable and meaningful way. In this regard, our comprehensive evaluation of the sunscreen market in the United States, together with a study demonstrating that photostability may be easily accounted for, and a positive correlation with in vivo measures of UVA photoprotection, all support the view that UV substrate spectrophotometry and calculation of the critical wavelength provide a convenient, reproducible, and adaptacross the spectral interval of 290 to 400 nm. Whereas a well-equipped testing laboratory can routinely determine such parameters, the consumer, unfortunately, cannot.
To address this insufficiency, some measure of broad-spectrum efficacy is needed that is versatile, reliable, and independent of SPF, yet ensures broadspectrum protection commensurate with SPF. Moreover, such information needs to be communi- able procedure for evaluating the breadth of UV protection. Moreover, when coupled with the in vivo SPF value, critical wavelength provides a simple, transparent, and explicit means of communicating broadspectrum photoprotection to the consumer.
In the seminal publication proposing the critical wavelength method, 28 5 categories of broad-spectrum protection were proposed. The difference between wavelengths dividing these 5 categories was logarithmic, based on the well-characterized UVinduced biologic response patterns. The highest classification was a critical wavelength greater than or equal to 370 nm. From the evaluation of 59 commercial products, the overwhelming majority (93%) had a critical wavelength value greater than 340 nm. However, only 10% of the 59 products evaluated achieved a critical wavelength of 370 nm or greater. More importantly, these products contained a recognized long-wavelength UVA1 filter. In addition, the same filters formulated in model sunscreen creams achieved critical wavelength values of more than 370 nm. Based on these data, a more conservative product classification would be the selection of a single critical wavelength at which a sunscreen product would either pass or fail to achieve a broad-spectrum classification. In this regard, a critical wavelength of greater than or equal to 370 nm appears to be a rigorous minimum that sunscreen products would need to achieve to be labeled broad-spectrum. In addition, such a simple pass/fail approach would readily accommodate advances in scientific knowledge regarding UVA end points and subsequent methods.
The absorption spectrum is the most relevant attribute of any sunscreen product. This can be measured with relatively inexpensive, readily available equipment by applying a sunscreen product evenly over a substrate. The resulting absorbance curve comprises 2 key attributes, namely, the amplitude and shape. The amplitude of the absorption curve reflects the degree of protection. However, the overall amplitude of the absorbance curve can vary significantly across repeated measurements, primarily because of the intrinsic link of this parameter to product application density and substrate topography. 32 This is precisely why attempts to develop in vitro measures of SPF have not succeeded; interlaboratory and intralaboratory variance is simply too high. The other key attribute of the absorption spectrum is the shape of the curve, that is, the efficiency at which the product attenuates one UV wavelength relative to another. In practice, the relative wavelength absorption efficiency is generally very consistent across repeated measurements, resulting in an absorbance-by-wavelength fingerprint, characteristic of the sunscreen active system. From the absorption curve, the efficiency for which a sunscreen product attenuates UV can be expressed in several ways. For example, Sayre and Agin 33 measured the spectral absorbance of several sunscreen products and calculated UVA protection factors by using the product of the standard solar spectrum and the CIE erythemal action spectrum 6 convoluted with the sunscreen absorption spectrum. However, this erythemally weighted measure is strongly associated with SPF 34 and is therefore a redundant measure. Other uses of the absorption spectrum to estimate UVA photoprotection include methods based on a ratio of UVA/UVB absorbance (eg, the UK "Boots" Star Method 35 ) and the critical wavelength method as proposed by Diffey. 28 The latter approach can be distinguished from others on the basis of its total reliance on the shape of the absorption curve. To date, however, it is true to say that the rigor and versatility of this approach have been largely unreported outside of cross-industry methods task forces.
A commonly voiced concern with in vitro procedures is their relationship to an in vivo end point. In the case of long-wavelength UVA protection, there is currently no end point or surrogate that can be used with confidence. The importance of this should not be underestimated. For example, there are several in vivo measures of UVA photoprotection using erythema or pigmentation as the end point. Erythema is already accounted for in SPF testing and is heavily weighted in the short UVA wavelengths. Arguably the most well-studied and published of the in vivo UVA photoprotection methods is the so-called immediate pigment darkening (IPD) method. IPD is the transient gray-brown discoloration of the skin that develops immediately after exposure to predominantly long-wavelength UVA. It was first described by Hausser 36 and more recently proposed as an in vivo method to evaluate UVA photoprotection. 37, 38 The efforts to gain widespread use of this method have largely stalled, in part related to questions of the biologic significance of the end-point measure. Moreover, pigmentation, whether immediate or persistent, is reported to be an oxygen-dependent phenomenon, 39 which, by definition, would make such an end-point measure UV dose-rate dependent. Thus, unlike SPF testing in which UV-dose reciprocity has been reported to exist, 40 UVA-induced pigment changes have been reported to be both irradiance dependent 26 and independent. 37 Regardless, we believe the present in vivo approaches for UVA photoprotection have multiple shortcomings, thereby limiting their potential usefulness.
To establish the biologic relevance of in vitro measures, we determined the relationship between criti-cal wavelength values and previously published PPF values. The PPF method using 8-methoxypsoralen as a topical or oral sensitizer has also been used to evaluate UVA photoprotection. Because psoralens are photogenotoxic, 41 their routine use for evaluating sunscreen products is ethically untenable. Nonetheless, we used results from historical studies to establish the relationship between critical wavelength values and in vivo UVA photoprotection. There was a very positive relationship between the PPF and the critical wavelength for sunscreen products with similar SPFs. This relationship establishes the in vivo significance of the critical wavelength when in vivo SPF is taken into account and further supports the meaningful information derived from this measure.
Finally, we found that the procedure can readily account for photoinstability changes through UV preirradiation. Because of known photochemical processes, this accounting for potential photoinstability can only be appropriately and reliably accomplished through full-spectrum UV (290-400 nm) product irradiation; this is a unique characteristic of this approach versus other procedures that irradiate using sources filtered to give UVA only.
The results presented herein highlight that a sunscreen product's critical wavelength value must always be considered in conjunction with its corresponding in vivo SPF. To be explicit, if two products (A and B) share the same critical wavelength but exhibit differing in vivo SPF values (15 and 30, respectively), then according to the critical wavelength calculation, product B must have been formulated with significantly more long-wavelength UVA protection than product A (ie, commensurate with SPF). In short, a combination of in vivo SPF and critical wavelength provides a complete description of a product's inherent photoprotective characteristics; SPF describes the amplitude of protection (at a given application rate) and critical wavelength provides a reliable measure of the product's spectral absorption capability. No other efficacy measures are needed.
The conclusion from this comprehensive assessment of the critical wavelength procedure is that it provides a rapid, inexpensive, and reliable measure of broad-spectrum protection, which is independent of SPF, yet ensures broad-spectrum protection commensurate with SPF. The method also provides a routine yet sensitive means of differentiating and classifying sunscreen products and, importantly, eliminates the need to subject volunteers to acute exposures of high-dose, nonterrestrial UV, the human health risks of which are still poorly understood.
